Life Sciences: Corporate/Commercial | USA

Judith Hasko is the chair of the transactional department and co-chair of life sciences practice at WilmerHale. She is held in high regard for her work advising life sciences clients on the negotiation of licensing and collaboration agreements, financings and M&A transactions. She acts for an impressive range of leading companies in fields including pharmaceuticals and medical devices.

Kingsley Taft is co-chair of Goodwin's life sciences group. He advises life sciences businesses at every stage of operation and in a wide range of processes, such as strategic alliances and collaborations, venture financings and company formation.

Mitchell Bloom is global chair of Goodwin’s life sciences practice. He advises emerging innovator companies, investment banks and venture capital firms worldwide on capital markets offerings, M&A and venture capital transactions.

Emily Leonard is managing partner of Covington’s Palo Alto office. She advises clients on matters including licensing and technology transfers, joint ventures and strategic partnerships, as well as research and operations-related commercial agreements.

Cheston Larson advises biotech and other life sciences companies through all stages of their life cycle. His practice focuses on corporate and financing transactions. His work covers venture financing, IPOs and M&A transactions.

David Bauer is an experienced adviser to emerging and established life sciences companies on a wide range of transactional matters. He frequently counsels on licensing agreements, IP aspects of transactions and R&D agreements, among other things.

Hannah England is a notable practitioner who advises global biotechnology and pharmaceutical companies on licensing and collaboration transactions. She is also noted for her work on asset acquisitions, royalty monetization and research and development financing arrangements.

Lila Hope is an established practitioner who is well equipped to support life sciences clients on a wide range of corporate mandates. She has particular strength in cross-border licensing transactions.

Olivia Tyrrell is called on to advise multinational pharmaceutical clients on corporate transactions, particularly cross-border mergers, acquisitions, joint ventures, and strategic alliances.

Randall Sunberg is the chair of the North American healthcare and life sciences group. He advises an array of clients in the life sciences sector, including venture capital and private equity firms, as well as biotech, pharmaceuticals, diagnostic and medical device companies. He is highly recommended for corporate, financing and partnering transactions.

Stephen Thau is cochair of the life science and healthtech group at Orrick, Herrington & Sutcliffe. He represents companies in a range of transactional matters including financings, strategic acquisitions and licensing agreements.